NCT01183286

Brief Summary

Adolescents with cystic fibrosis are particularly vulnerable to poor adherence, which negatively impacts their health status, quality of life and long term survival. CFFONE: A Cell Phone Support Program for Adolescents with Cystic Fibrosis, will make use of cutting-edge technology- a broadband capable, cellular telephone keyed into a highly-interactive informational web site. This web site will provide engaging online learning activities and resources specific to adolescents with cystic fibrosis. We believe the information and activities contained in CFFONE will improve adolescents knowledge, attitudes, and practices around cystic fibrosis and that adolescents exposed to the CFFONE program will demonstrate an increase in adherence to their treatment regimens and related improvements in their health status and quality of life.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for phase_2

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 17, 2010

Completed
15 days until next milestone

Study Start

First participant enrolled

September 1, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Last Updated

August 17, 2010

Status Verified

August 1, 2010

Enrollment Period

1.6 years

First QC Date

August 13, 2010

Last Update Submit

August 16, 2010

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cystic Fibrosis Knowledge Questionnaire (CFK)

    The CFK assess participants' CF-related knowledge. The CFK consists of 42 multiple-choice items, with scores reported as percentage correct.

    The CFK will be administered at baseline, month 3, month 6 and month 9.

Secondary Outcomes (2)

  • Cystic Fibrosis Questionnaire-Revised (CFQ-R)

    The CFQ-R will be administered at baseline, month 3, month 6 and month 9.

  • Pharmacy Refill Data

    Pharmacy Refill Data will be collected at baseline for the 12 months prior to enrollment; and again after the 9 month clinic visit for the 9 months of the study. The Prescribed Treatment Plan will be collected at baseline, month 3, month 6 and month 9.

Study Arms (2)

CFFONE

ACTIVE COMPARATOR
Behavioral: CFFONE

CF website

PLACEBO COMPARATOR
Behavioral: CF website

Interventions

CFFONEBEHAVIORAL

A password-protected, secure website, which can be accessed via a web capable cell phone. The website contains age appropriate medical and behavioral information, disease management tools and social networking features for adolescents and young people who have Cystic Fibrosis.

CFFONE
CF websiteBEHAVIORAL

A CF-related educational website which has some areas of CF information and services relevant to adolescents.

CF website

Eligibility Criteria

Age11 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Have a diagnosis of Cystic Fibrosis
  • Be within the target age range of 11-20 years old at enrollment -Have regular access to an internet connected computer that does not prevent access to websites (i.e. a firewall) -

You may not qualify if:

  • Have a developmental disorder that would affect ability to respond to survey questions -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 13, 2010

First Posted

August 17, 2010

Study Start

September 1, 2010

Primary Completion

April 1, 2012

Last Updated

August 17, 2010

Record last verified: 2010-08